BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21382920)

  • 21. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
    Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.
    Akar NA; Adekile A
    Med Princ Pract; 2008; 17(5):404-8. PubMed ID: 18685282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric vasoocclusive crisis and weather conditions.
    Rogovik AL; Persaud J; Friedman JN; Kirby MA; Goldman RD
    J Emerg Med; 2011 Nov; 41(5):559-65. PubMed ID: 20576392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Admission and length of stay due to painful vasoocclusive crisis in children.
    Rogovik AL; Li Y; Kirby MA; Friedman JN; Goldman RD
    Am J Emerg Med; 2009 Sep; 27(7):797-801. PubMed ID: 19683107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of screening laboratory studies in pediatric patients with sickle cell pain episodes.
    Chapman JI; El-Shammaa EN; Bonsu BK
    Am J Emerg Med; 2004 Jul; 22(4):258-63. PubMed ID: 15258863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of psychiatric diagnoses on hospital length of stay in children with sickle cell anemia.
    Myrvik MP; Campbell AD; Davis MM; Butcher JL
    Pediatr Blood Cancer; 2012 Feb; 58(2):239-43. PubMed ID: 21425450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease.
    Panepinto JA; Brousseau DC; Hillery CA; Scott JP
    Pediatr Blood Cancer; 2005 Feb; 44(2):182-6. PubMed ID: 15390359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing clinical severity in children with sickle cell disease. Preliminary results from a cooperative study.
    Bray GL; Muenz L; Makris N; Lessin LS
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):50-4. PubMed ID: 8311173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral morphine protocol for sickle cell crisis pain.
    Conti C; Tso E; Browne B
    Md Med J; 1996 Jan; 45(1):33-5. PubMed ID: 8569458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Emergencies in adults with sickle cell disease].
    Godeau B
    Bull Acad Natl Med; 2004; 188(3):507-15; discussion 515-7. PubMed ID: 15584659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of foetal haemoglobin on the frequency of vaso-occlusive crisis in sickle cell anaemia patients.
    Enosolease ME; Ejele OA; Awodu OA
    Niger Postgrad Med J; 2005 Jun; 12(2):102-5. PubMed ID: 15997258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of copeptin, C-reactive protein and cortisol in different severity groups of sickle cell anaemia.
    Akinlade KS; Atere AD; Rahamon SK; Olaniyi JA
    Niger J Physiol Sci; 2013 Dec; 28(2):159-64. PubMed ID: 24937391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.
    Morris CR; Kuypers FA; Larkin S; Vichinsky EP; Styles LA
    J Pediatr Hematol Oncol; 2000; 22(6):515-20. PubMed ID: 11132219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence-based management of sickle cell disease in the emergency department.
    Glassberg J
    Emerg Med Pract; 2011 Aug; 13(8):1-20; quiz 20. PubMed ID: 22164362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute pancreatitis during sickle cell vaso-occlusive painful crisis.
    Ahmed S; Siddiqui AK; Siddiqui RK; Kimpo M; Russo L; Mattana J
    Am J Hematol; 2003 Jul; 73(3):190-3. PubMed ID: 12827657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vaso-occlusive crisis of sickle cell child in Brazzaville drugs news].
    Mbika Cardorelle A; Okoko A; Mouko A
    Arch Pediatr; 2010 Mar; 17(3):295-6. PubMed ID: 20034770
    [No Abstract]   [Full Text] [Related]  

  • 37. A pilot study on the efficacy of ketorolac plus tramadol infusion combined with erythrocytapheresis in the management of acute severe vaso-occlusive crises and sickle cell pain.
    de Franceschi L; Finco G; Vassanelli A; Zaia B; Ischia S; Corrocher R
    Haematologica; 2004 Nov; 89(11):1389-91. PubMed ID: 15531461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Derivation of a risk assessment tool for emergency department patients with sickle cell disease.
    Bernard AW; Lindsell CJ; Venkat A
    Emerg Med J; 2008 Oct; 25(10):635-9. PubMed ID: 18843058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-annexin V IgG and IgM antibodies in sickle cell disease patients with vaso-occlusive crisis.
    Sater MS; Mahdi N; Al-Absi IK; Al-Subaie AM; Al-Ola K; Mohammed FA; Almawi WY
    Ann Hematol; 2011 Sep; 90(9):1031-6. PubMed ID: 21340721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute chest syndrome after splenectomy in children with sickle cell disease.
    Ghantous S; Al Mulhim S; Al Faris N; Abushullaih B; Shalak F; Yazbeck S
    J Pediatr Surg; 2008 May; 43(5):861-4. PubMed ID: 18485954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.